Microbot Medical Inc. Files 8-K
Ticker: MBOT · Form: 8-K · Filed: Jan 27, 2025 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Jan 27, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-statements, disclosure
TL;DR
Microbot Medical filed a routine 8-K on Jan 27, 2025. No major news.
AI Summary
Microbot Medical Inc. filed an 8-K on January 27, 2025, reporting other events and financial statements. The company, incorporated in Delaware, has its principal executive offices in Braintree, MA. This filing is a routine update and does not appear to disclose specific new material events or financial figures.
Why It Matters
This 8-K filing serves as a standard disclosure for Microbot Medical Inc., indicating the submission of financial statements and other events to the SEC.
Risk Assessment
Risk Level: low — This filing is a standard 8-K for reporting financial statements and other events, with no indication of significant new developments or risks.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- January 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Braintree, MA (location) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Microbot Medical Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of January 27, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on January 27, 2025.
In which state is Microbot Medical Inc. incorporated?
Microbot Medical Inc. is incorporated in Delaware.
What is the address of Microbot Medical Inc.'s Principal Executive Offices?
The address of Microbot Medical Inc.'s Principal Executive Offices is 288 Grove Street, Suite 388, Braintree, MA 02184.
Does this 8-K filing disclose any specific new material events or financial figures?
Based on the provided text, this 8-K filing appears to be a routine report of financial statements and other events, and does not disclose specific new material events or financial figures.
Filing Stats: 475 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-01-27 17:00:11
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
- $1.00 — the Company's common stock has been at $1.00 per share or more for 15 consecutive bu
Filing Documents
- form8-k.htm (8-K) — 36KB
- 0001493152-25-003818.txt ( ) — 207KB
- mbot-20250127.xsd (EX-101.SCH) — 3KB
- mbot-20250127_lab.xml (EX-101.LAB) — 33KB
- mbot-20250127_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: January 27, 2025